Want to see JP:7679 full AI Analyst Report?
7679 Stock Chart & Stats
¥2167.00
-¥102.00(-4.91%)
At close: 4:00 PM EST
¥2167.00
-¥102.00(-4.91%)
Day’s Range― - ―
52-Week Range¥1,611.00 - ¥2,346.00
Previous CloseN/A
Volume101.50K
Average Volume (3M)32.44K
Market Cap
¥32.57B
Enterprise Value¥56.73B
Total Cash (Recent Filing)¥6.97B
Total Debt (Recent Filing)¥15.41B
Price to Earnings (P/E)8.2
Beta0.49
Next Earnings
Jul 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.29%
Share Statistics
EPS (TTM)227.00
Shares Outstanding19,740,220
10 Day Avg. Volume22,110
30 Day Avg. Volume32,443
Financial Highlights & Ratios
PEG Ratio-1.88
Price to Book (P/B)1.01
Price to Sales (P/S)0.25
P/FCF Ratio-4.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained mid-single-digit top-line growth indicates steady customer demand and market penetration in the retail pharmacy segment. That durable revenue trajectory supports longer-term planning, supplier leverage and gradual expansion, providing predictable operating scale over months.
Resilient Retail Pharmacy Model And ScaleA store-based pharmacy model with recurring prescription sales and diversified front‑end merchandise creates stable, repeat customer flows. Scale enables buying and merchandising efficiencies that support margins and inventory turns, a structural advantage across a multi-month horizon.
Built Equity And Capital BaseA history of steadily accumulated equity provides a financial buffer that underpins investment and operational continuity. This stronger capital base improves resilience to shocks, supports funding for store upgrades, and gives management room to execute strategy over the medium term.
Bears Say
Volatile And Negative Free Cash FlowLarge swings into negative free cash flow constrain the company's ability to self-fund capex, deleveraging or shareholder returns. Persistently weak FCF reduces financial flexibility, raises refinancing risk and can force trade-offs between investment and liquidity across coming quarters.
Higher Leverage From 2026 Debt Step-upA marked increase in debt elevates interest and principal servicing needs, tightening cash flow coverage. Higher leverage limits strategic optionality, increases vulnerability to cost shocks, and can constrain investment or M&A plans over the medium term without stronger cash generation.
Margin Compression And Thin ProfitabilityShrinking gross and EBITDA margins reduce the cushion to absorb cost inflation or competitive price pressure. With relatively low net margins, earnings are sensitive to small revenue or cost shifts, making it harder to rebuild cash buffers or fund growth without efficiency gains.
Yakuodo Holdings Co., Ltd. News
7679 FAQ
What was Yakuodo Holdings Co., Ltd.’s price range in the past 12 months?
Yakuodo Holdings Co., Ltd. lowest stock price was ¥1611.00 and its highest was ¥2346.00 in the past 12 months.
What is Yakuodo Holdings Co., Ltd.’s market cap?
Yakuodo Holdings Co., Ltd.’s market cap is ¥32.57B.
When is Yakuodo Holdings Co., Ltd.’s upcoming earnings report date?
Yakuodo Holdings Co., Ltd.’s upcoming earnings report date is Jul 06, 2026 which is in 3 days.
How were Yakuodo Holdings Co., Ltd.’s earnings last quarter?
Yakuodo Holdings Co., Ltd. released its earnings results on Apr 08, 2026. The company reported ¥45.85 earnings per share for the quarter, beating the consensus estimate of N/A by ¥45.85.
Is Yakuodo Holdings Co., Ltd. overvalued?
According to Wall Street analysts Yakuodo Holdings Co., Ltd.’s price is currently Overvalued.
Does Yakuodo Holdings Co., Ltd. pay dividends?
Yakuodo Holdings Co., Ltd. pays a Annually dividend of ¥30 which represents an annual dividend yield of 1.29%. See more information on Yakuodo Holdings Co., Ltd. dividends here
What is Yakuodo Holdings Co., Ltd.’s EPS estimate?
Yakuodo Holdings Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yakuodo Holdings Co., Ltd. have?
Yakuodo Holdings Co., Ltd. has 19,740,220 shares outstanding.
What happened to Yakuodo Holdings Co., Ltd.’s price movement after its last earnings report?
Yakuodo Holdings Co., Ltd. reported an EPS of ¥45.85 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.631%.
Which hedge fund is a major shareholder of Yakuodo Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in JP:7679
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yakuodo Holdings Co., Ltd.
YAKUODO HOLDINGS Co., Ltd. primarily oversees the operation of drugstores throughout Japan via its various subsidiary entities. This enterprise, established in 1978, manages a total of 358 retail locations and is officially headquartered in Morioka, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---